Q2 2026 sales backlog

Subject kind: financing
Statement date: 2026-08-11
Promised amount: 104.0 billion USD
Current status: stated

The claim, verbatim

CoreWeave reported Q2 2026 sales backlog of $104 billion

Source (primary)

‘Pharma Bro’ Martin Shkreli ‘Covered’ CoreWeave Short Position: CRWV Stock Slides For Third Session - TradingView (-, news_article)
View cached copy (2026-09-01)Live source ↗

Quote: “The company's sales backlog – or future sales from recurring customers – reached $104 billion, nearly doubling the order book it reported in November.”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms ‘Pharma Bro’ Martin Shkreli ‘Covered’ CoreWeave Short Position: CRWV Stock Slides For Third Session - TradingView

Quote: “The company's sales backlog – or future sales from recurring customers – reached $104 billion, nearly doubling the order book it reported in November.”

View cached copy (2026-09-01)Live source ↗

Record of changes

September 1, 2026 — statedlater found incorrect

Automated extraction from the cited source. ~~Recorded automatically from the cited source when it was published, then queued for evidence review.~~

September 2, 2026 — withdrawnlater found incorrect

Evidence review against the cited source. ~~The source document discusses CoreWeave's quarterly results and stock movements but contains no mention of a $104 billion sales backlog, doubling, or November comparisons.~~

September 2, 2026 — stated

Correction after re-verification. Re-verification found the cited source does support this claim. The earlier withdrawal was made in error and has been reversed. The attributed quote appears verbatim in the cited source (deterministic check).